Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 2/3 2 Phase 1 2 Phase 3 1 Phase 1/2 1

Status

Completed 37 Active not recruiting 12 Terminated 7 Recruiting 7 Unknown 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Paclitaxel 24 Oxaliplatin 24 Capecitabine 24 Gemcitabine 21 Cisplatin 21 Fluorouracil 20 Drug Therapy 18 Docetaxel 18 Carboplatin 17 pembrolizumab 15 Leucovorin 15 Irinotecan 15 Radiotherapy 12 tislelizumab 11 Magnetic Resonance Spectroscopy 10 Bevacizumab 10 Specimen Handling 9 Pemetrexed 9 Radiation 8 Injections 8 Cetuximab 8 toripalimab 7 Surgical Procedures, Operative 7 Radiotherapy, Intensity-Modulated 7 Azacitidine 7 venetoclax 6 sintilimab 6 Trastuzumab 6 Topotecan 6 Standard of Care 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × Calcium Dobesilate × Clear all

NCT07285239 2026-05-18

PrE1005

PrECOG, LLC.

Phase 3 Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡